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Abstract
Lung carc nosarcoma  s an  nfrequently b phas c tumor composed of carc nomatous and sarcomatous components. It  s d v ded  nto
endobronch al (squamous-type) and per pheral (glandular type) categor es. The carc nomatous component  s usually a squamous
carc noma, and the sarcomatous component usually resembles a f brosarcoma or a mal gnant f brous h st ocytoma. The presence of
rhabdomyoblast c d fferent at on  n such neoplasms  s exceed ngly rare. There are strong assoc at ons w th smok ng and asbestos s. In th s
study, we descr be a un que case of a 43-year-old man w th a 75 packet/year smok ng h story  n whom a rare m xed mal gnant tumor of the
lung was d agnosed and treated by left pneumonectomy. H stolog cal exam nat on of the resected spec men showed squamous cell
carc noma and rhabdomyosarcoma components. Although rare, the assoc at on of a sarcomato d carc noma of the lung w th squamous cell
carc noma and rhabdomyosarcomatous component  s poss ble and should be kept  n m nd when deal ng w th these unusual tumors.
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Full Text
Sarcomato d carc nomas of the lung are a group of poorly d fferent ated non small cell carc nomas, ma nly squamous cell carc noma (45-
70%) that conta ns a component of sarcoma or sarcoma-l ke d fferent at on. Carc nosarcoma  s a m xture of carc noma and sarcoma
conta n ng d fferent ated sarcomatous elements. The sarcomatous component  s most often poorly d fferent ated sp ndle cell sarcoma.
However, a careful search always shows areas of more spec f c sarcomatous d fferent at on, most often rhabdomyosarcoma. [1] 
Although the development of carc nosarcoma  s more closely assoc ated w th smok ng, there are cases reported to be caused by asbestos
exposure. [2],[3] We present a carc nosarcoma case  n an act ve smoker w th  nterest ng macroscop c v ews. The long tud nal sect on of the
postpneumonectomy pathology spec men extends to the left ma n bronchus and all lower subsegment bronch   n the shape of a glove f nger,
f ll ng the a rways w thout  nvad ng the wall. The underl ned phrase does not make a sense.
A 43-year-old male had a smok ng h story of 75 packs/year and cont nued to smoke at the t me of adm ss on. He had started to suffer from
dyspnea e ght months ago and had lost 5 kg  n the last 3 months. He presented at the hosp tal w th  ncreas ng shortness of breath  n the last
few months and the chest x-ray revealed atelectas s  n the left lung [F gure 1]a. Resp ratory sounds were not heard on the left hem thorax on
phys cal exam nat on. A soft t ssue appearance 53 × 18 × 15 mm  n s ze and obl terat ng the left ma n bronchus, start ng  mmed ately from
the car na  n the lumen of left ma n bronchus was detected on computed tomography (CT) of the chest. In add t on, there was a complete
atelectas s of the left lung, and there were not patholog cal lymph nodes [F gure 1]b. Bronchoscop c b ops es were taken from the mass
located  n the left ma n bronchus start ng approx mately 2 cm d stally from car na. The pathology result was reported as mal gnant
mesenchymal tumor. No other abnormal uptake bes des the left lung mass, that showed hypermetabol c  nvolvement and a max mum
standard zed uptake value (SUVmax) value of 7.4, was observed  n the PET-CT scan. Cran al MRI was normal. The pat ent underwent a left
thoracotomy. Pleural flu d was found and a sample was sent for  ntraoperat ve exam nat on, wh ch proved to be negat ve for mal gnant cells.
Then, b ops es from lymph nodes  n nodal stat ons 4L, 5, 7, 9, and 10 were performed, and were followed by a left pneumonectomy. At gross
exam nat on of the resected spec men, the left ma n bronchus was found to be f lled w th the mass, progress ng to the lower lobe bronchus
and subsegment bronch  but there was no macroscop c  nvas on of bronch al walls [F gure 2]a and b. The tumor was or g nated from lower
lobe bronch al mucosa. The m croscop c exam nat on was d agnost c of sarcomato d carc noma (squamous cell carc noma and
rhabdomyosarcoma) and all lymph nodes were reported as react ve. The pat ent had an uneventful postoperat ve course and was placed
 nto a chemotherapy program w th (I fosfam d 5000mg/m 2 , doxorub c ne 40mg/m 2 , v ncr st ne 2, 3 mg/m 2 ). One year after operat on,
there are no s gns of recurrence.{F gure 1}{F gure 2}
Sarcomatous change  n a carc noma  s a relat vely rare event but has been reported by many  nvest gators  n var ous anatom c s tes such as
the sk n, head and neck, thyro d gland, gastro ntest nal tract, l ver, gallbladder, pancreas, mammary gland, ur nary tract, gen tal tract, and
lung. [4] Sarcomato d carc nomas of the lung are generally bel eved to be more aggress ve and have a poorer prognos s than ord nary lung
carc nomas. [5],[6] However, some stud es have found sarcomato d carc nomas not to be s gn f cantly more aggress ve than ord nary lung
carc nomas. [4] F shback et al., report that cases beyond stage I, w th lymph node  nvolvement, a tumor s ze larger than 5 cm, w th pleural
 nvas on and the sarcomato d component mak ng up more than 50% of the tumor are assoc ated w th poor prognos s. [7] Our case was stage
II, w th 6 cm tumor s ze, w th no pleural  nvas on or lymph node  nvolvement, and the sarcomato d component cons sted of more than 50% of
the tumor. The carc noma extended from the ma n bronchus to the subsegments of the upper and lower lobes as f nger-l ke extens ons but
d d not  nvade the a rways. We speculate whether the presence or absence of a rway  nvas on could be a postoperat ve prognost c factor  n
add t on to the cr ter a def ned by F shback et al. The pat ent  s be ng followed-up and h s cond t on w ll be closely mon tored.
Smok ng plays a pr mary role  n the et ology of carc nosarcoma as  n other lung cancers. Atyp cal and hyperplast c changes are h stolog cally
observed  n the bronch al ep thel um  n 10% of smokers and atyp cal cells are observed at a rate as h gh as 96.7%. Squamous cell
carc nomas metastas ze later than other types, and usually tend to spread locally. [8] However, there may be necrot c and cyst c areas  n the
rhabdomyosarcoma mass or  t can extend and  nvade ne ghbor ng vessels and bronch . Thorax local zat on  s also reported to be a poor
prognost c factor. [9] Our case was stage II, w th a 6 cm tumor s ze, and the sarcomato d part cons sted of more than 50% of the tumor and
w th thorax local zat on, all poor prognost c factors. The absence of lymph node  nvolvement and pleural  nvas on were good prognost c
factors. 
In a lung carc nosarcoma case publ shed  n 2001, act n and v ment n pos t v ty were detected on sta n ng  n add t on to the squamous cell
carc noma but the case was reported as carc nosarcoma as rhabdomyosarcoma or osteosarcoma could not be  dent f ed. [10] Our case was
a squamous cell carc noma w th a moderately d fferent ated ep thel al component. The major ty of the sarcomato d component was
composed of rhabdomyosarcoma areas cons st ng of v ment n, skeletal muscle act n, and desm n pos t ve sp ndle-shaped and rhabdo d
cells. 
Surg cal resect on of the lung tumor  s the ma nstay of the treatment but we adm n stered chemo-rad otherapy to the pat ent as lung
carc nosarcoma  s rarely seen and st ll has no clearly  dent f ed treatment models and surv val analys s.
In conclus on, although rare, the assoc at on of a sarcomato d carc noma of the lung w th squamous cell carc noma and
rhabdomyosarcomatous component  s poss ble and should be kept  n m nd when deal ng w th these unusual tumors.
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